ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
MethyAnno: An Interpretable Automated Annotation Method Leveraging Multi-Scale Information and Metric Learning Framework for scDNAm Data.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Single-cell DNA methylation (scDNAm) sequencing provides unique insights into epigenetic heterogeneity and cell-specific regulatory landscapes. However, accurate cell type annotation for scDNAm data remains challenging, as the distinct data distribution of scDNAm hinders the adaptation of annotation methods from other omics, and specialized annotation tools for scDNAm are currently lacking. Here, MethyAnno is proposed as an interpretable deep metric learning framework that leverages multi-scale information for accurate cell type annotation of scDNAm data. Additionally, MethyAnno enables generalized category discovery in open-set scenarios by utilizing density-based clustering to automatically estimate the number of novel cell types, while simultaneously deciphering cell-type-specific epigenetic signatures for biological interpretability. Extensive experiments demonstrate that MethyAnno excels in cross-dataset annotation and novel type discovery, showing exceptional robustness in few-shot scenarios for rare cell types. Moreover, interpretability analysis in the human brain dataset correctly recovers the genetic link between Sst interneurons and epilepsy heritability, the association of OPC cells with Alzheimer's disease, as well as the regulatory role of Pvalb cells in synaptic plasticity. Taken together, these findings establish MethyAnno as a robust and biologically interpretable tool for accurate cell type annotation and downstream epigenetic analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.